- call +1-201-465-4211
- email sales@mrinsights.biz
A biological implant is manufactured to replace a damaged or missing biological structure. Biological implants are man made devices and design to help the biological anatomy function.
Biological implants help replace or stabilize injured tissue and are used in non-union repair, fractures, lens prosthesis, total joint replacements.
Scope of the Report:
This report studies the Biological Implants market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biological Implants market by product type and applications/end industries.
In 2017, North America accounted for the largest share of over 50%. This largest share is attributed to the simultaneous development of surgical procedures for extremities using implants. Also, presence of large number of key participants operating in this region coupled with high incidence of accidental injury that features most of the reconstructive procedures are expected to project demand for this market in North America.
The global Biological Implants market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biological Implants.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Integra LifeSciences Corporation
NuVasive, Inc
Edward LifeSciences Corporation
Stryker Corporation
LifeCell corporation
Medtronic
RTI Surgical, Inc
BioPolymer GmbH & Co. KG
Johnson & Johnson
Baxter International, Inc.
Vericel Corporation
Alphatec Spine, Inc
CryoLife
Maxigen Biotech, Inc.
IOP Ophthalmic Products, Inc.
CONMED
Allergan Plc
BioTissue
Auto Tissue Berlin GmbH
MiMedx Group, Inc.
Organogenesis, Inc.
Osiris Therapeutics, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Autografts
Allografts
Xenografts
Market Segment by Applications, can be divided into
Cardiovascular Implants
Orthopedic Implants
Dental Implants
Soft Tissue Implants
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biological Implants Market Overview
1.1 Product Overview and Scope of Biological Implants
1.2 Classification of Biological Implants by Types
1.2.1 Global Biological Implants Revenue Comparison by Types (2017-2023)
1.2.2 Global Biological Implants Revenue Market Share by Types in 2017
1.2.3 Autografts
1.2.4 Allografts
1.2.5 Xenografts
1.3 Global Biological Implants Market by Application
1.3.1 Global Biological Implants Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cardiovascular Implants
1.3.3 Orthopedic Implants
1.3.4 Dental Implants
1.3.5 Soft Tissue Implants
1.4 Global Biological Implants Market by Regions
1.4.1 Global Biological Implants Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biological Implants Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biological Implants Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biological Implants Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biological Implants Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biological Implants Status and Prospect (2013-2023)
1.5 Global Market Size of Biological Implants (2013-2023)
2 Manufacturers Profiles
2.1 Integra LifeSciences Corporation
2.1.1 Business Overview
2.1.2 Biological Implants Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Integra LifeSciences Corporation Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.2 NuVasive, Inc
2.2.1 Business Overview
2.2.2 Biological Implants Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 NuVasive, Inc Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.3 Edward LifeSciences Corporation
2.3.1 Business Overview
2.3.2 Biological Implants Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Edward LifeSciences Corporation Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.4 Stryker Corporation
2.4.1 Business Overview
2.4.2 Biological Implants Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Stryker Corporation Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.5 LifeCell corporation
2.5.1 Business Overview
2.5.2 Biological Implants Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 LifeCell corporation Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.6 Medtronic
2.6.1 Business Overview
2.6.2 Biological Implants Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Medtronic Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.7 RTI Surgical, Inc
2.7.1 Business Overview
2.7.2 Biological Implants Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 RTI Surgical, Inc Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.8 BioPolymer GmbH & Co. KG
2.8.1 Business Overview
2.8.2 Biological Implants Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 BioPolymer GmbH & Co. KG Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.2 Biological Implants Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Johnson & Johnson Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.10 Baxter International, Inc.
2.10.1 Business Overview
2.10.2 Biological Implants Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Baxter International, Inc. Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.11 Vericel Corporation
2.11.1 Business Overview
2.11.2 Biological Implants Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Vericel Corporation Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.12 Alphatec Spine, Inc
2.12.1 Business Overview
2.12.2 Biological Implants Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Alphatec Spine, Inc Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.13 CryoLife
2.13.1 Business Overview
2.13.2 Biological Implants Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CryoLife Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.14 Maxigen Biotech, Inc.
2.14.1 Business Overview
2.14.2 Biological Implants Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Maxigen Biotech, Inc. Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.15 IOP Ophthalmic Products, Inc.
2.15.1 Business Overview
2.15.2 Biological Implants Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 IOP Ophthalmic Products, Inc. Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.16 CONMED
2.16.1 Business Overview
2.16.2 Biological Implants Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 CONMED Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.17 Allergan Plc
2.17.1 Business Overview
2.17.2 Biological Implants Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Allergan Plc Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.18 BioTissue
2.18.1 Business Overview
2.18.2 Biological Implants Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 BioTissue Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.19 Auto Tissue Berlin GmbH
2.19.1 Business Overview
2.19.2 Biological Implants Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Auto Tissue Berlin GmbH Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.20 MiMedx Group, Inc.
2.20.1 Business Overview
2.20.2 Biological Implants Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 MiMedx Group, Inc. Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.21 Organogenesis, Inc.
2.21.1 Business Overview
2.2.2 Biological Implants Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Organogenesis, Inc. Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
2.22 Osiris Therapeutics, Inc.
2.22.1 Business Overview
2.22.2 Biological Implants Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Osiris Therapeutics, Inc. Biological Implants Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biological Implants Market Competition, by Players
3.1 Global Biological Implants Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biological Implants Players Market Share
3.2.2 Top 10 Biological Implants Players Market Share
3.3 Market Competition Trend
4 Global Biological Implants Market Size by Regions
4.1 Global Biological Implants Revenue and Market Share by Regions
4.2 North America Biological Implants Revenue and Growth Rate (2013-2018)
4.3 Europe Biological Implants Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biological Implants Revenue and Growth Rate (2013-2018)
4.5 South America Biological Implants Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biological Implants Revenue and Growth Rate (2013-2018)
5 North America Biological Implants Revenue by Countries
5.1 North America Biological Implants Revenue by Countries (2013-2018)
5.2 USA Biological Implants Revenue and Growth Rate (2013-2018)
5.3 Canada Biological Implants Revenue and Growth Rate (2013-2018)
5.4 Mexico Biological Implants Revenue and Growth Rate (2013-2018)
6 Europe Biological Implants Revenue by Countries
6.1 Europe Biological Implants Revenue by Countries (2013-2018)
6.2 Germany Biological Implants Revenue and Growth Rate (2013-2018)
6.3 UK Biological Implants Revenue and Growth Rate (2013-2018)
6.4 France Biological Implants Revenue and Growth Rate (2013-2018)
6.5 Russia Biological Implants Revenue and Growth Rate (2013-2018)
6.6 Italy Biological Implants Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biological Implants Revenue by Countries
7.1 Asia-Pacific Biological Implants Revenue by Countries (2013-2018)
7.2 China Biological Implants Revenue and Growth Rate (2013-2018)
7.3 Japan Biological Implants Revenue and Growth Rate (2013-2018)
7.4 Korea Biological Implants Revenue and Growth Rate (2013-2018)
7.5 India Biological Implants Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biological Implants Revenue and Growth Rate (2013-2018)
8 South America Biological Implants Revenue by Countries
8.1 South America Biological Implants Revenue by Countries (2013-2018)
8.2 Brazil Biological Implants Revenue and Growth Rate (2013-2018)
8.3 Argentina Biological Implants Revenue and Growth Rate (2013-2018)
8.4 Colombia Biological Implants Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biological Implants by Countries
9.1 Middle East and Africa Biological Implants Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biological Implants Revenue and Growth Rate (2013-2018)
9.3 UAE Biological Implants Revenue and Growth Rate (2013-2018)
9.4 Egypt Biological Implants Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biological Implants Revenue and Growth Rate (2013-2018)
9.6 South Africa Biological Implants Revenue and Growth Rate (2013-2018)
10 Global Biological Implants Market Segment by Type
10.1 Global Biological Implants Revenue and Market Share by Type (2013-2018)
10.2 Global Biological Implants Market Forecast by Type (2018-2023)
10.3 Autografts Revenue Growth Rate (2013-2023)
10.4 Allografts Revenue Growth Rate (2013-2023)
10.5 Xenografts Revenue Growth Rate (2013-2023)
11 Global Biological Implants Market Segment by Application
11.1 Global Biological Implants Revenue Market Share by Application (2013-2018)
11.2 Biological Implants Market Forecast by Application (2018-2023)
11.3 Cardiovascular Implants Revenue Growth (2013-2018)
11.4 Orthopedic Implants Revenue Growth (2013-2018)
11.5 Dental Implants Revenue Growth (2013-2018)
11.6 Soft Tissue Implants Revenue Growth (2013-2018)
12 Global Biological Implants Market Size Forecast (2018-2023)
12.1 Global Biological Implants Market Size Forecast (2018-2023)
12.2 Global Biological Implants Market Forecast by Regions (2018-2023)
12.3 North America Biological Implants Revenue Market Forecast (2018-2023)
12.4 Europe Biological Implants Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biological Implants Revenue Market Forecast (2018-2023)
12.6 South America Biological Implants Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biological Implants Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biological Implants Picture
Table Product Specifications of Biological Implants
Table Global Biological Implants and Revenue (Million USD) Market Split by Product Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
